Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels.

Kevin P CunninghamD Euan MacIntyreAlistair A Mathie Emma L Veale

Published in: Acta physiologica (Oxford, England) (2019)

These data show that in contrast to rodent channels, doxapram is a potent inhibitor of both TASK-1 and TASK-3 human channels, providing further understanding of the pharmacological profile of doxapram in humans and informing the development of new therapeutic agents.

Keyphrases

endothelial cells
induced pluripotent stem cells
pluripotent stem cells
electronic health record
computed tomography
big data
working memory
deep learning
artificial intelligence